Molecular Oncology Group, Precision Nutrition and Health, IMDEA Food Institute, CEI UAM + CSIC, Ctra. de Cantoblanco 8, 28049 Madrid, Spain.
NATAC BIOTECH, Electronica 7, 28923 Madrid, Spain.
Biomolecules. 2021 Mar 10;11(3):412. doi: 10.3390/biom11030412.
Obesity is the epidemic of the 21st century. In developing countries, the prevalence of obesity continues to rise, and obesity is occurring at younger ages. Obesity and associated metabolic stress disrupt the whole-body physiology. Adipocytes are critical components of the systemic metabolic control, functioning as an endocrine organ. The enlarged adipocytes during obesity recruit macrophages promoting chronic inflammation and insulin resistance. Together with the genetic susceptibility (single nucleotide polymorphisms, SNP) and metabolic alterations at the molecular level, it has been highlighted that key modifiable risk factors, such as those related to lifestyle, contribute to the development of obesity. In this scenario, urgent therapeutic options are needed, including not only pharmacotherapy but also nutrients, bioactive compounds, and natural extracts to reverse the metabolic alterations associated with obesity. Herein, we first summarize the main targetable processes to tackle obesity, including activation of thermogenesis in brown adipose tissue (BAT) and in white adipose tissue (WAT-browning), and the promotion of energy expenditure and/or fatty acid oxidation (FAO) in muscles. Then, we perform a screening of 20 natural extracts (EFSA approved) to determine their potential in the activation of FAO and/or thermogenesis, as well as the increase in respiratory capacity. By means of innovative technologies, such as the study of their effects on cell bioenergetics (Seahorse bioanalyzer), we end up with the selection of four extracts with potential application to ameliorate the deleterious effects of obesity and the chronic associated inflammation.
肥胖是 21 世纪的流行病。在发展中国家,肥胖的患病率持续上升,肥胖发生的年龄也越来越小。肥胖症和相关的代谢压力会破坏全身的生理机能。脂肪细胞是全身代谢控制的关键组成部分,起着内分泌器官的作用。肥胖时,增大的脂肪细胞招募巨噬细胞,促进慢性炎症和胰岛素抵抗。再加上遗传易感性(单核苷酸多态性,SNP)和分子水平的代谢改变,人们已经强调指出,一些关键的可改变的风险因素,如与生活方式有关的因素,有助于肥胖的发展。在这种情况下,需要紧急的治疗选择,包括不仅是药物治疗,还包括营养素、生物活性化合物和天然提取物,以逆转与肥胖相关的代谢改变。在此,我们首先总结了可用于治疗肥胖症的主要靶向过程,包括激活棕色脂肪组织(BAT)和白色脂肪组织(WAT 褐变)的产热作用,以及促进肌肉中的能量消耗和/或脂肪酸氧化(FAO)。然后,我们对 20 种天然提取物(EFSA 批准)进行了筛选,以确定它们在激活 FAO 和/或产热作用以及增加呼吸能力方面的潜力。通过创新技术,如研究它们对细胞生物能量学的影响( Seahorse 生物分析仪),我们最终选择了四种具有潜在应用价值的提取物,可以改善肥胖及其相关慢性炎症的不良影响。